tiprankstipranks
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Income Statement

Compare
57 Followers

bioAffinity Technologies, Inc. Income Statement

Last quarter (Q3 2024), bioAffinity Technologies, Inc.'s total revenue was $2.35M, an increase of 687.44% from the same quarter last year. In Q3, bioAffinity Technologies, Inc.'s net income was $-2.00M. See bioAffinity Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.53M$ 4.80K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 791.62K$ 4.34K$ -4.82K$ -22.24K$ -40.28K
Operating Expenses
$ 8.76M$ 4.02M$ 2.21M$ 2.60M$ 3.05M
Depreciation and Amortization
$ 249.59K$ 10.18K$ 4.82K$ 22.24K$ 40.28K
EBITDA
$ -7.63M$ -5.61M$ -2.20M$ -6.86M$ -3.05M
Operating Income
$ -7.97M$ -4.01M$ -2.21M$ -2.60M$ -3.09M
Other Income/Expenses
$ 57.21K$ -4.14M$ -4.12M$ -4.66M$ -212.06K
Pretax Income
$ -7.92M$ -8.15M$ -6.32M$ -7.27M$ -3.30M
Net Income
$ -7.94M$ -8.15M$ -6.33M$ -7.27M$ -3.31M
Per Share Metrics
Basic EPS
$ -0.91$ -1.81$ -0.86$ -0.99$ -0.45
Diluted EPS
$ -0.91$ -1.81$ -0.86$ -0.99$ -0.45
Weighted Average Shares Outstanding
8.75M 4.50M 7.38M 7.38M 7.38M
Weighted Average Shares Outstanding (Diluted)
8.75M 4.50M 7.38M 7.38M 7.38M
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis